OXYCODONE HYDROCHLORIDE | N200535 | GENUS LIFE SCIENCES INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Lehigh Valley Technologies, Inc. and Glenmark Generics, Inc. USA (Foley & Lar... FDA-2011-P-0433 · 5 docket documents Lehigh Valley Technologies, Inc. and Glenmark Generics, Inc. USA filed this citizen petition under sections 505(b), 505(j), and 505(q) of the FD&C Act requesting that the FDA stay approval of any pending ANDAs or 505(b)(2) NDAs for single entity oxycodone hydrochloride products unless the active pha | 505(q) Stay Request | 2011-06-09 | Partially Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.0787
per ml
Lowest NADAC/Unit
$0.0787
per ml
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 64950035450OXYCODONE HCL 5 MG/5 ML SOLN | $0.0787 | ML | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.